Nutt, David J.

Drug harms in the UK: a multicriteria decision analysis

Nutt, D. J., King, L. A., & Phillips, L. D. (2010) · The Lancet

Substance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk

Cited by 1,681

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,540

Trial of Psilocybin versus Escitalopram for Depression

Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021) · New England Journal of Medicine

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,391

Development of a rational scale to assess the harm of drugs of potential misuse

Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007) · The Lancet

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 1,302

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.

Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 1,252

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences

Psychedelics and Drug StudiesPain Management and Placebo Effect

Cited by 1,172

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 970

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 859

Sleep disorders as core symptoms of depression

Nutt, D., Wilson, S., & Paterson, L. (2008) · Dialogues in Clinical Neuroscience

Sleep and related disordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 839

Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression.

Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 808

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 676

Homological scaffolds of brain functional networks

Petri, G., Expert, P., Turkheimer, F., Carhart-Harris, R., Nutt, D., Hellyer, P. J., & Vaccarino, F. (2014) · Journal of The Royal Society Interface

Functional Brain Connectivity StudiesTopological and Geometric Data Analysis

Cited by 675

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 617

Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression

Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 589

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 587

Tryptophan metabolism in the central nervous system: medical implications

Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A. W., & Lowry, C. A. (2006) · Expert Reviews in Molecular Medicine

Tryptophan and brain disordersAmino Acid Enzymes and Metabolism

Cited by 519

Increased global functional connectivity correlates with LSD-induced ego dissolution

Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., Laufs, H., Leech, R., McGonigle, J., Crossley, N., et al. (2016) · Current Biology

Psychedelics and Drug StudiesFunctional Brain Connectivity Studies

Cited by 503

Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI).

Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016) · Frontiers in Human Neuroscience

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 470

Predicting responses to psychedelics: a prospective study

Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 417

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007) · Journal of Psychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 366

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 347

Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies

Andersen, K. A. A., Carhart‐Harris, R., Nutt, D. J., & Erritzoe, D. (2021) · Acta Psychiatrica Scandinavica

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 347

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 343

Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin

Lebedev, A. V., Lövdén, M., Rosenthal, G., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2015) · Human Brain Mapping

Psychedelics and Drug StudiesFunctional Brain Connectivity Studies

Cited by 339